Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 15Active not recruiting 7Not yet recruiting 3Terminated 1Completed 1Available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Neoplasms 9Melanoma 8Lung Neoplasms 7Breast Neoplasms 7Multiple Myeloma 6Leukemia, Myeloid, Acute 6Ovarian Neoplasms 5Brain Neoplasms 5Pancreatic Neoplasms 4Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Endometrial Neoplasms 4Colorectal Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Myelodysplastic Syndromes 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Carcinoma, Renal Cell 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2Small Cell Lung Carcinoma 2Rectal Neoplasms 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Thyroid Neoplasms × 30 days × Clear all
NCT06465017 2026-05-28

ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer

The First Affiliated Hospital of Xiamen University

Phase NA Terminated
149 enrolled
Head & Neck

Disease, Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡